Cue Biopharma Long Term Deferred Assets (Quarterly) Analysis

Cue Biopharma, Inc. (CUE)

0.3774 +0.08 (+26.26%) USD | NASDAQ | Jan 21, 16:00

0.4171 +0.04 (+10.52%) After-Hours: 19:33

View Long Term Deferred Assets (Quarterly) for CUE.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Long Term Deferred Assets (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Long Term Deferred Assets (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Long Term Deferred Assets (Quarterly) Benchmarks

Start Trial

Insmed, Inc.	--
Puma Biotechnology, Inc.	Upgrade
Mersana Therapeutics, Inc. (DELISTED)	--
Adaptive Biotechnologies Corp.	--
NovaBay Pharmaceuticals, Inc.	--